卒中后抑郁治疗对HAMD改善的网络Meta分析
结果显示第4周针刺联合氟西汀最优,第8周rTMS联合帕罗西汀最优,抗抑郁药联合辅助治疗均优于单药治疗。
要点
- 第4周HAMD改善以针刺联合氟西汀最优(vs 安慰剂MD -8.9)。
- 第8周HAMD改善以rTMS联合帕罗西汀最优(vs 安慰剂MD -13)。
- 抗抑郁药联合辅助治疗在HAMD改善及50%改善率上优于单药治疗。
核心结论
- 抗抑郁药联合辅助治疗可能增强疗效,在HAMD变化及50%改善率上优于抗抑郁药单药治疗。
- 针刺联合氟西汀在第4周对卒中后抑郁更有效,rTMS联合帕罗西汀在第8周更有效。
研究设计与样本
- 采用贝叶斯网络Meta分析,评估各治疗与安慰剂的均数差或比值比,汇总为平均值和95%置信区间。
主要发现
- 第4周HAMD变化:针刺联合氟西汀 vs 安慰剂MD -8.9(95% CI [-15, -2.9]),针刺联合帕罗西汀 vs 安慰剂MD -8.5(95% CI [-15, -2.5])。
- 第8周HAMD变化:rTMS联合帕罗西汀 vs 安慰剂MD -13(95% CI [-17, -7.9])。
- 药物联合辅助治疗在HAMD改善率超过50%的患者比例上也更优。
临床怎么用
- 卒中后抑郁第4周可考虑针刺联合氟西汀以改善HAMD评分。
- 卒中后抑郁第8周可考虑rTMS联合帕罗西汀以改善HAMD评分。
- 抗抑郁药联合辅助治疗可能优于单药治疗,但需结合患者具体情况选择。
局限性
- 针刺联合氟西汀是否优于rTMS联合帕罗西汀用于第8周卒中后抑郁尚需进一步研究确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction: Post-stroke depression (PSD) is a common mental health problem after cerebrovascular accidents. There are several treatments that have been shown to be effective in treating post-stroke depression. However, it is not clear which treatment is more effective. Methods: In this meta-analysis, an appropriate search strategy was used to search eligible randomized controlled trials (RCTs) on different treatments to treat patients with Post-stroke depression published up to December 2021 from the CNKI, PubMed, and Cochrane Library. We assessed the mean difference or odds ratio between each treatment and placebo and summarized them as the average and 95% confidence interval (CI) by conducting Bayesian network meta-analyses. Results: By constructing a Bayesian network meta-analysis, we found that acupuncture combined with fluoxetine (vs placebo MD, -8.9; 95% CI, [-15, -2.9]) or paroxetine (vs placebo MD,-8.5; 95% CI, [-15, -2.5]) was the most effective for change in Hamilton depression scale (HAMD) at the end of the 4th week. For change in Hamilton depression scale at the end of the 8th week, rTMS combined with paroxetine (vs placebo MD, -13; 95% CI, [-17, -7.9]) had the greatest amount of change. The efficacy of medication combined with adjuvant therapy was also superior for the percentage of patients with Hamilton depression scale change over 50%. Discussion: The combination of antidepressants with adjuvant therapy may enhance the efficacy of antidepressants and achieve better results than antidepressant monotherapy in both Hamilton depression scale changes at the end of week 4 or 8 and 50% Hamilton depression scale improvement rate. Acupuncture combined with fluoxetine treatment was more effective in the treatment of post-stroke depression at week 4, while rTMS combined with paroxetine was more effective at week 8. Further research is needed to determine whether acupuncture combined with fluoxetine is better than rTMS combined with paroxetine for post-stroke depression at week 8.
引用
- Zhang J, Song Z, Gui C, et al. Treatments to post-stroke depression, which is more effective to HAMD improvement? A network meta-analysis. Front Pharmacol. 2022. PMID: 36601053. doi:10.3389/fphar.2022.1035895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。